Parathyroid Carcinoma

An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB)

Elliot A. Asare*, Cord Sturgeon, David J. Winchester, Lei Liu, Bryan Palis, Nancy D. Perrier, Douglas B. Evans, David P. Winchester, Tracy S. Wang

*Corresponding author for this work

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background: Parathyroid carcinoma is a rare disease. Conflicting results on prognostic factors and extent of surgical resection for patients with parathyroid carcinoma have been made based on small sample sizes. A large, robust dataset is needed to help address some of the controversies. Methods: A retrospective review of patients with parathyroid carcinoma in the National Cancer Data Base from 1985 to 2006 was performed. Characteristics of the cohort and type of treatment were evaluated. Prognostic factors were assessed with Cox proportional hazards regression models and 5- and 10-year OS rates were determined. Results: There were 733 evaluable patients with a mean age of 56.1 ± 15.3 years (median 57, range 15–89) and mean tumor size of 29.6 ± 18.4 mm (median 25.0 mm, range 10.0–150.0). Tumor size, age at diagnosis, male sex, positive nodal status, and complete tumor resection had hazard ratios for death of 1.02 (1.01–1.02, p < 0.0001), 1.06 (1.05–1.07, p < 0.0001), 1.67 (1.24–2.25, p = 0.0008), 1.25 (0.57–2.76, p = 0.6), and 0.42 (0.22–0.81, p = 0.01), respectively, on multivariable analysis. Patients who had removal of the parathyroid tumor with concomitant resection of adjacent organs had HR for death of 0.70 (0.35–1.41, p = 0.3). The 5- and 10-year OS rates were 82.3 and 66 % respectively. Conclusions: Patient age, tumor size, and sex have modest effects on survival in patients with parathyroid carcinoma. A staging system with prognostic value for parathyroid carcinoma should include at least these pertinent prognostic factors.

Original languageEnglish (US)
Pages (from-to)3990-3995
Number of pages6
JournalAnnals of Surgical Oncology
Volume22
Issue number12
DOIs
StatePublished - Nov 1 2015

Fingerprint

Parathyroid Neoplasms
Databases
Neoplasms
Rare Diseases
Proportional Hazards Models
Sample Size
Survival

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Asare, Elliot A. ; Sturgeon, Cord ; Winchester, David J. ; Liu, Lei ; Palis, Bryan ; Perrier, Nancy D. ; Evans, Douglas B. ; Winchester, David P. ; Wang, Tracy S. / Parathyroid Carcinoma : An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB). In: Annals of Surgical Oncology. 2015 ; Vol. 22, No. 12. pp. 3990-3995.
@article{bdcf834b4ac44ceeba258291a30fdcbe,
title = "Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB)",
abstract = "Background: Parathyroid carcinoma is a rare disease. Conflicting results on prognostic factors and extent of surgical resection for patients with parathyroid carcinoma have been made based on small sample sizes. A large, robust dataset is needed to help address some of the controversies. Methods: A retrospective review of patients with parathyroid carcinoma in the National Cancer Data Base from 1985 to 2006 was performed. Characteristics of the cohort and type of treatment were evaluated. Prognostic factors were assessed with Cox proportional hazards regression models and 5- and 10-year OS rates were determined. Results: There were 733 evaluable patients with a mean age of 56.1 ± 15.3 years (median 57, range 15–89) and mean tumor size of 29.6 ± 18.4 mm (median 25.0 mm, range 10.0–150.0). Tumor size, age at diagnosis, male sex, positive nodal status, and complete tumor resection had hazard ratios for death of 1.02 (1.01–1.02, p < 0.0001), 1.06 (1.05–1.07, p < 0.0001), 1.67 (1.24–2.25, p = 0.0008), 1.25 (0.57–2.76, p = 0.6), and 0.42 (0.22–0.81, p = 0.01), respectively, on multivariable analysis. Patients who had removal of the parathyroid tumor with concomitant resection of adjacent organs had HR for death of 0.70 (0.35–1.41, p = 0.3). The 5- and 10-year OS rates were 82.3 and 66 {\%} respectively. Conclusions: Patient age, tumor size, and sex have modest effects on survival in patients with parathyroid carcinoma. A staging system with prognostic value for parathyroid carcinoma should include at least these pertinent prognostic factors.",
author = "Asare, {Elliot A.} and Cord Sturgeon and Winchester, {David J.} and Lei Liu and Bryan Palis and Perrier, {Nancy D.} and Evans, {Douglas B.} and Winchester, {David P.} and Wang, {Tracy S.}",
year = "2015",
month = "11",
day = "1",
doi = "10.1245/s10434-015-4672-3",
language = "English (US)",
volume = "22",
pages = "3990--3995",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "12",

}

Asare, EA, Sturgeon, C, Winchester, DJ, Liu, L, Palis, B, Perrier, ND, Evans, DB, Winchester, DP & Wang, TS 2015, 'Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB)', Annals of Surgical Oncology, vol. 22, no. 12, pp. 3990-3995. https://doi.org/10.1245/s10434-015-4672-3

Parathyroid Carcinoma : An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB). / Asare, Elliot A.; Sturgeon, Cord; Winchester, David J.; Liu, Lei; Palis, Bryan; Perrier, Nancy D.; Evans, Douglas B.; Winchester, David P.; Wang, Tracy S.

In: Annals of Surgical Oncology, Vol. 22, No. 12, 01.11.2015, p. 3990-3995.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Parathyroid Carcinoma

T2 - An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB)

AU - Asare, Elliot A.

AU - Sturgeon, Cord

AU - Winchester, David J.

AU - Liu, Lei

AU - Palis, Bryan

AU - Perrier, Nancy D.

AU - Evans, Douglas B.

AU - Winchester, David P.

AU - Wang, Tracy S.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Background: Parathyroid carcinoma is a rare disease. Conflicting results on prognostic factors and extent of surgical resection for patients with parathyroid carcinoma have been made based on small sample sizes. A large, robust dataset is needed to help address some of the controversies. Methods: A retrospective review of patients with parathyroid carcinoma in the National Cancer Data Base from 1985 to 2006 was performed. Characteristics of the cohort and type of treatment were evaluated. Prognostic factors were assessed with Cox proportional hazards regression models and 5- and 10-year OS rates were determined. Results: There were 733 evaluable patients with a mean age of 56.1 ± 15.3 years (median 57, range 15–89) and mean tumor size of 29.6 ± 18.4 mm (median 25.0 mm, range 10.0–150.0). Tumor size, age at diagnosis, male sex, positive nodal status, and complete tumor resection had hazard ratios for death of 1.02 (1.01–1.02, p < 0.0001), 1.06 (1.05–1.07, p < 0.0001), 1.67 (1.24–2.25, p = 0.0008), 1.25 (0.57–2.76, p = 0.6), and 0.42 (0.22–0.81, p = 0.01), respectively, on multivariable analysis. Patients who had removal of the parathyroid tumor with concomitant resection of adjacent organs had HR for death of 0.70 (0.35–1.41, p = 0.3). The 5- and 10-year OS rates were 82.3 and 66 % respectively. Conclusions: Patient age, tumor size, and sex have modest effects on survival in patients with parathyroid carcinoma. A staging system with prognostic value for parathyroid carcinoma should include at least these pertinent prognostic factors.

AB - Background: Parathyroid carcinoma is a rare disease. Conflicting results on prognostic factors and extent of surgical resection for patients with parathyroid carcinoma have been made based on small sample sizes. A large, robust dataset is needed to help address some of the controversies. Methods: A retrospective review of patients with parathyroid carcinoma in the National Cancer Data Base from 1985 to 2006 was performed. Characteristics of the cohort and type of treatment were evaluated. Prognostic factors were assessed with Cox proportional hazards regression models and 5- and 10-year OS rates were determined. Results: There were 733 evaluable patients with a mean age of 56.1 ± 15.3 years (median 57, range 15–89) and mean tumor size of 29.6 ± 18.4 mm (median 25.0 mm, range 10.0–150.0). Tumor size, age at diagnosis, male sex, positive nodal status, and complete tumor resection had hazard ratios for death of 1.02 (1.01–1.02, p < 0.0001), 1.06 (1.05–1.07, p < 0.0001), 1.67 (1.24–2.25, p = 0.0008), 1.25 (0.57–2.76, p = 0.6), and 0.42 (0.22–0.81, p = 0.01), respectively, on multivariable analysis. Patients who had removal of the parathyroid tumor with concomitant resection of adjacent organs had HR for death of 0.70 (0.35–1.41, p = 0.3). The 5- and 10-year OS rates were 82.3 and 66 % respectively. Conclusions: Patient age, tumor size, and sex have modest effects on survival in patients with parathyroid carcinoma. A staging system with prognostic value for parathyroid carcinoma should include at least these pertinent prognostic factors.

UR - http://www.scopus.com/inward/record.url?scp=84943350542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943350542&partnerID=8YFLogxK

U2 - 10.1245/s10434-015-4672-3

DO - 10.1245/s10434-015-4672-3

M3 - Article

VL - 22

SP - 3990

EP - 3995

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 12

ER -